Publications by authors named "Andrew N Cornforth"

Claim this Profile
P
Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines.
Robert O Dillman, Gabriel I Nistor, Bryce T McLelland, Candace Hsieh, Aleksandra J Poole, Andrew N Cornforth

Oncotarget· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma.
Robert O Dillman, Andrew N Cornforth, Edward F McClay, Carol Depriest

Melanoma Manag· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses.
Robert O Dillman, Andrew N Cornforth, Gabriel I Nistor, Edward F McClay, Thomas T Amatruda

J Immunother Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell vaccines for melanoma: past, present and future.
Robert O Dillman, Gabriel I Nistor, Andrew N Cornforth

Melanoma Manag· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma.
Xiaojin Wang, Michael E Bayer, Xiaosong Chen, Craig Fredrickson, Andrew N Cornforth

J Surg Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fascin-1 knock-down of human glioma cells reduces their microvilli/filopodia while improving their susceptibility to lymphocyte-mediated cytotoxicity.
Neil T Hoa, Lisheng Ge, Kate L Erickson, Carol A Kruse, Andrew N Cornforth

Am J Transl Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.
Neil T Hoa, Lisheng Ge, Rajeev B Tajhya, Christine Beeton, Andrew N Cornforth

Am J Transl Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma.
Ahmed M Aref, Neil T Hoa, Lisheng Ge, Anshu Agrawal, Maria Dacosta-Iyer, Andrew N Cornforth

Onco Targets Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?
Robert O Dillman, Andrew N Cornforth, Gabriel Nistor

Expert Opin Biol Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia.
Lisheng Ge, Andrew N Cornforth, Neil T Hoa, Christina Delgado, Shiun Kwei Chiou

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
Robert O Dillman, Andrew N Cornforth, Carol Depriest, Edward F McClay, Thomas T Amatruda

J Immunother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy.
Lisheng Ge, Neil T Hoa, Andrew N Cornforth, Daniela A Bota, Anthony Mai

J Immunol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines.
Robert O Dillman, Gary B Fogel, Andrew N Cornforth, Senthamil R Selvan, Patric M Schiltz

Cancer Biother Radiopharm· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of interferon-γ-treated melanoma tumor cells for use in dendritic cell-based immunotherapy.
Andrew N Cornforth, Abner W Fowler, Denysha J Carbonell, Eric Fan, Robert O Dillman

Cancer Biother Radiopharm· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine.
Robert O Dillman, Andreea A Nanci, Scott T Williams, Richard B Kim, Russell L Hafer, Andrew N Cornforth

Cancer Biother Radiopharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes.
Neil Hoa, Lisheng Ge, Yurii Kuznetsov, Alex McPherson, Andrew N Cornforth

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma.
Robert Owen Dillman, Christopher Michael Duma, Robin Anne Ellis, Andrew Nimitz Cornforth, Patric Michael Schiltz

J Immunother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy.
Andrew N Cornforth, Gregory J Lee, Abner W Fowler, Denysha J Carbonell, Robert O Dillman

J Clin Immunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.
Robert O Dillman, Senthamil R Selvan, Patric M Schiltz, Edward F McClay, Neil M Barth, Andrew N Cornforth

Cancer Biother Radiopharm· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a human primary prostate carcinoma cell line, HH870.
Senthamil R Selvan, Andrew N Cornforth, Nagesh P Rao, Yvonne A Reid, Patric M Schiltz

Prostate· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis